Cargando…

TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB

SIMPLE SUMMARY: Bladder cancer (BCa) is considered one of the most common neoplasms of the urology system. Cisplatin-based chemotherapy has been the primary treatment for patients with advanced or metastatic BCa. Nevertheless, cisplatin resistance often limits the treatment of bladder cancer. We exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xing, Ji, Chen, Wu, Chen, Kang, Zhu, Shaoming, Lin, Fangyou, Qi, Yucheng, Zhang, Yunlong, Han, Shangting, Rao, Ting, Ruan, Yuan, Zhao, Sheng, Yu, Weimin, Cheng, Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562889/ https://www.ncbi.nlm.nih.gov/pubmed/36230734 http://dx.doi.org/10.3390/cancers14194809

Ejemplares similares

HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation
por: Han, Shangting, et al.
Publicado: (2022)

Classification and clinical significance of the posterior group of renal calyces
por: Qi, Yucheng, et al.
Publicado: (2023)

Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer
por: Kołat, Damian, et al.
Publicado: (2021)

Distinct Activities of Tfap2A and Tfap2B in the Specification of GABAergic Interneurons in the Developing Cerebellum
por: Zainolabidin, Norliyana, et al.
Publicado: (2017)

Corrigendum: Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer
por: Kołat, Damian, et al.
Publicado: (2021)

METTL3 potentiates resistance to cisplatin through m(6)A modification of TFAP2C in seminoma
por: Wei, Jingchao, et al.
Publicado: (2020)

SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN/AKT/GSK3β signaling pathway through P53
por: Zou, Fan, et al.
Publicado: (2023)

Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer
por: Nordentoft, Iver, et al.
Publicado: (2011)

Knockdown of ZBTB11 impedes R‐loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer
por: Chen, Lei, et al.
Publicado: (2022)

Functional Divergence of Mammalian TFAP2a and TFAP2b Transcription Factors for Bidirectional Sleep Control
por: Hu, Yang, et al.
Publicado: (2020)

Photobiomodulation With Blue Laser Inhibits Bladder Cancer Progression
por: Xia, Yuqi, et al.
Publicado: (2021)

Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes
por: Orso, Francesca, et al.
Publicado: (2010)

TFAP2B mutation and dental anomalies
por: Tanasubsinn, Natchaya, et al.
Publicado: (2017)

Identification of inflammatory response and alternative splicing in acute kidney injury and experimental verification of the involvement of RNA-binding protein RBFOX1 in this disease
por: Lin, Fangyou, et al.
Publicado: (2022)

Glioblastoma cellular cross-talk converges on NF-κB to attenuate EGFR inhibitor sensitivity
por: Zanca, Ciro, et al.
Publicado: (2017)

SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β‐catenin pathway
por: Chen, Wu, et al.
Publicado: (2021)

Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer
por: Li, Yangle, et al.
Publicado: (2019)

Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway
por: Xue, Yanshi, et al.
Publicado: (2018)

TfAP-2 is required for night sleep in Drosophila
por: Kucherenko, Mariya M., et al.
Publicado: (2016)

Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin
por: Cai, Shijiao, et al.
Publicado: (2020)

Knockdown of Akt Sensitizes Osteosarcoma Cells to Apoptosis Induced by Cisplatin Treatment
por: Zhang, Guoyou, et al.
Publicado: (2011)

Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental Assays
por: Chen, Kang, et al.
Publicado: (2021)

Knockdown of circ_0060745 alleviates acute myocardial infarction by suppressing NF‐κB activation
por: Zhai, Changlin, et al.
Publicado: (2020)

Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter
por: Jiang, Wei, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of TFAP2 Family Members in Bladder Cancer from Database and FFPE Sample
por: Yuan, Feng, et al.
Publicado: (2023)

TFAP2 transcription factors are regulators of lipid droplet biogenesis
por: Scott, Cameron C, et al.
Publicado: (2018)

TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF
por: Seberg, Hannah E., et al.
Publicado: (2017)

Overexpression of Tfap2a in Mouse Oocytes Impaired Spindle and Chromosome Organization
por: Lin, Juan, et al.
Publicado: (2022)

Inhibition of hepatocyte nuclear factor 1β contributes to cisplatin nephrotoxicity via regulation of nf‐κb pathway
por: Zhang, Yan, et al.
Publicado: (2021)

BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer
por: Kuang, Chun-mei, et al.
Publicado: (2017)

Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROS
por: Pan, Xiaobo, et al.
Publicado: (2022)

Inhibition of the NF-κB Signaling Pathway Alleviates Pyroptosis in Bladder Epithelial Cells and Neurogenic Bladder Fibrosis
por: Chen, Jing, et al.
Publicado: (2023)

Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function
por: Yu, Xiaowen, et al.
Publicado: (2018)

TFAP2C regulates transcription in human naive pluripotency by opening enhancers
por: Pastor, William A., et al.
Publicado: (2018)

Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling Pathway
por: Li, Ling, et al.
Publicado: (2020)

MALT1 is required for EGFR induced NF-κB activation and contributes to EGFR-driven lung cancer progression
por: Pan, Deng, et al.
Publicado: (2015)

MTHFD2 promotes PD‐L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer
por: Li, Linzhi, et al.
Publicado: (2023)

TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018)

HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells
por: Lu, Hao, et al.
Publicado: (2016)

Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF-κB pathway in EGFR-mutant NSCLC
por: Li, Ling, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_30hiuk192ea0akr4sj14cfq6i7